A Radiologist's Guide to Treatment Response Criteria in Oncologic Imaging: Anatomic Imaging Biomarkers

被引:12
作者
Rezai, Pedram [1 ]
Pisaneschi, Mark J. [1 ]
Feng, Chun [1 ]
Yaghmai, Vahid [2 ]
机构
[1] John H Stroger Jr Hosp, Dept Radiol, Chicago, IL 60612 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA
关键词
anatomic imaging biomarker; imaging biomarker; RECIST; volumetric evaluation; WHO guideline; TUMOR RESPONSE; SOLID TUMORS; HEPATOCELLULAR-CARCINOMA; NEOADJUVANT CHEMOTHERAPY; DRUG-DEVELOPMENT; CLINICAL-TRIALS; VOLUMETRIC MEASUREMENTS; PULMONARY METASTASES; COMPUTED-TOMOGRAPHY; IMATINIB MESYLATE;
D O I
10.2214/AJR.12.9862
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this article is to describe the imaging biomarkers of treatment response and provide an overview of anatomic imaging biomarkers. CONCLUSION. Imaging biomarkers of treatment response have evolved into the primary endpoint of response in most phase 2 studies. Anatomic imaging biomarkers are applied to depict change in tumor size in response to treatment and are currently the most commonly applied method of treatment response evaluation.
引用
收藏
页码:237 / 245
页数:9
相关论文
共 50 条
[31]   Molecular imaging for monitoring treatment response in breast cancer patients [J].
Bensch, Frederike ;
van Kruchten, Michel ;
Lamberts, LaetitiaE. ;
Schroder, Carolien P. ;
Hospers, Geke A. P. ;
Brouwers, Adrienne H. ;
van Vugt, Marcel A. T. M. ;
de Vries, Elisabeth G. E. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 717 (1-3) :2-11
[32]   Oncologic Imaging End-Points for the Assessment of Therapy Response [J].
Serkova, Natalie J. ;
Garg, Kavita ;
Bradshaw-Pierce, Erica L. .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2009, 4 (01) :36-53
[33]   Advances in Imaging Techniques to Guide Therapies and Monitor Response to the Treatment of Musculoskeletal Injuries [J].
Horne, Caitlyn R. ;
Tufts, Sara .
VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2023, 39 (03) :489-501
[34]   Imaging of castration-resistant prostrate cancer: development of imaging response biomarkers [J].
Morisson, Courtney ;
Jeraj, Robert ;
Liu, Glenn .
CURRENT OPINION IN UROLOGY, 2013, 23 (03) :230-236
[35]   Cost-Effectiveness of Imaging Tumor Response Criteria in Hepatocellular Cancer After Transarterial Chemoembolization [J].
Wu, Xiao ;
Chapiro, Julius ;
Malhotra, Ajay .
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2021, 18 (07) :927-934
[36]   Prevalence of Imaging Biomarkers to Guide the Planning of Acute Stroke Reperfusion Trials [J].
Jiang, Bin ;
Ball, Robyn L. ;
Michel, Patrik ;
Jovin, Tudor ;
Desai, Manisha ;
Eskandari, Ashraf ;
Naqvi, Zack ;
Wintermark, Max .
STROKE, 2017, 48 (06) :1675-+
[37]   Fluid and imaging biomarkers for Huntington's disease [J].
Zeun, Paul ;
Scahill, Rachael I. ;
Tabrizi, Sarah J. ;
Wild, Edward J. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 97 :67-80
[38]   The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know [J].
Sala, Evis ;
Rockall, Andrea G. ;
Freeman, Susan J. ;
Mitchell, Donald G. ;
Reinhold, Caroline .
RADIOLOGY, 2013, 266 (03) :717-740
[39]   Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy [J].
Sahani, Dushyant V. ;
Jiang, Tao ;
Hayano, Koichi ;
Duda, Dan G. ;
Catalano, Onofrio A. ;
Ancukiewicz, Marek ;
Jain, Rakesh K. ;
Zhu, Andrew X. .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
[40]   Evaluation of early imaging response criteria in glioblastoma multiforme [J].
Adam Gladwish ;
Eng-Siew Koh ;
Jeremy Hoisak ;
Gina Lockwood ;
Barbara-Ann Millar ;
Warren Mason ;
Eugene Yu ;
Normand J Laperriere ;
Cynthia Ménard .
Radiation Oncology, 6